Content Type: Articles

Taylor DieringerSenior Staff Quality Engineer – Risk Management iRhythm Technologies, Inc. In medical device risk management, the structure of a hazard analysis greatly impacts both product development and post-market surveillance. A clear, intentional structure supports traceability, aligns with ISO 14971:2019, and enables effective risk control. This article explores three common structures for hazard analysis and […]

Created by: Valerie Mulholland, Senior Director / Principle Consultant, GMP Services Ltd & Anne Greene, Director PRST, Technological University, DublinThe Pharmaceutical Regulatory Science Team (PRST), founded in 2005, carries out research into strategies to address the challenges and opportunities of implementing science and risk-based decision making and manufacturing approaches. Since its inception, the PRST has […]

To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.

By Jane Weitzel, Quality Control Expert, and USP Council of Experts Member & Chair of the 2020-2025 General Chapters –Measurement and Data QualityFit for intended purpose is a key, central concept for USP <1220> Analytical Procedure Life Cycle, ICH Q2(R2) Validation of Analytical Procedures, and ICH Q14 Analytical Procedure Development. The performance criteria for the […]

To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.

Kim Huynh-Ba*, Pharmalytik LLC, and Christopher Latoz, Hollister Incorporated*Corresponding Author: kim.huynhba@pharmalytik.comAbstractPharmaceutical products require expiration dates and storage conditions on their labels, determined through stability studies conducted from clinical trials through post-approval. These studies ensure that any chemical, physical, or microbiological changes over time do not affect the product’s quality, safety, or efficacy. ICH Q1A(R2) provides […]

To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.

Ronald D Snee. PhD, Snee Associates, LLC, Newark, DE 19711The scientific method is fundamental to the operation and success of the pharmaceutical industry including the discovery of new products, development of the products using clinical trials and the manufacture of the products. The scientific method has three key components:Recognition and formulation of a problem Collection […]

To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.